list of glp 1 agonist drugs FDA Approved GLP-1 RAs and Their Indications Glucagon-like peptide-1 - Wikipedia

S2CID 83852654

Another 2025 survey published in JAMA Health Forum noted that, should Medicare pay for the drugs, it could avoid spending a hypothetical $18.2 billion on obesity-related health expenditures over 10 years while dishing out $65.9 billion annually on the GLP-1s by year 10, thereby negating any savings

Further, CDC population data from 2023 show that, in 23 states, 35% of adults have obesitya striking increase over the past ten years

In a recent study, treatment with liraglutide significantly reduced oxidative stress induced by high glucose levels

Hwang and A

In 2005, the FDA approved exenatide (Byetta) for the treatment of type 2 diabetes mellitus